Literature DB >> 7657553

Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy.

J T Rosenbaum1, S T Planck, X N Huang, L Rich, J C Ansel.   

Abstract

PURPOSE: Cytokines have been implicated in corneal inflammatory diseases. The authors sought to determine if corneal diseases with different patterns of inflammation are accompanied by characteristic patterns of cytokine expression.
METHODS: The authors used reverse transcription-polymerase chain reaction to detect mRNA for 12 specific cytokines from patients with Fuch's dystrophy (n = 7), pseudophakic bullous keratopathy (n = 12), or normal corneas (n = 4).
RESULTS: Using Wilcoxon rank sum analysis, mRNA for interleukin (IL)-1 alpha or IL-8 was significantly more abundant in corneas from patients with pseudophakic bullous keratopathy relative to either comparison group. mRNA for the T-cell marker, CD4, and for T-cell derived cytokines, IL-2, IL-4, and interferon gamma, could not be detected in any corneal sample. Message for IL-1 receptor antagonist and transforming growth factor-beta 1 or -beta 2 was readily detectable in most corneas regardless of diagnosis.
CONCLUSION: The findings indicate that the pattern of cytokine mRNA expression reflects differences in the pathogenesis of these corneal diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657553

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Inflammatory responses of corneal epithelial cells to Pseudomonas aeruginosa infection.

Authors:  Jing Zhang; Xin-Yi Wu; Fu-Shin X Yu
Journal:  Curr Eye Res       Date:  2005-07       Impact factor: 2.424

2.  Overexpression of IL-8 in the cornea induces ulcer formation in the SCID mouse.

Authors:  M Oka; K Norose; K Matsushima; C Nishigori; M Herlyn
Journal:  Br J Ophthalmol       Date:  2006-01-17       Impact factor: 4.638

3.  Orbital fibroblast chemokine modulation: effects of dexamethasone and cyclosporin A.

Authors:  M A Burnstine; S G Elner; V M Elner
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

4.  Ultrastructural morphology and expression of proteoglycans, betaig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy.

Authors:  S Akhtar; A J Bron; N R Hawksworth; R E Bonshek; K M Meek
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

5.  Effect of topical azithromycin on corneal innate immune responses.

Authors:  Zahra Sadrai; Amir Reza Hajrasouliha; Sunil Chauhan; Daniel R Saban; Mohammad H Dastjerdi; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-19       Impact factor: 4.799

6.  Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.

Authors:  Ying-Ting Chen; Stanislav Lazarev; Ahmad F Bahrami; Lisa B Noble; Feeling Y T Chen; Delu Zhou; Marianne Gallup; Mahesh Yadav; Nancy A McNamara
Journal:  Lab Invest       Date:  2012-01-09       Impact factor: 5.662

7.  Inflammatory cytokine gene expression in THP-1 cells exposed to Stachybotrys chartarum and Aspergillus versicolor.

Authors:  Ruoting Pei; Claudia K Gunsch
Journal:  Environ Toxicol       Date:  2011-03-07       Impact factor: 4.119

8.  Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas.

Authors:  Barbara Strzalka-Mrozik; Agnieszka Stanik-Walentek; Malgorzata Kapral; Malgorzata Kowalczyk; Jolanta Adamska; Joanna Gola; Urszula Mazurek
Journal:  Mol Vis       Date:  2010-02-05       Impact factor: 2.367

9.  Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.

Authors:  Francisco Amparo; Mohammad H Dastjerdi; Andre Okanobo; Giulio Ferrari; Leila Smaga; Pedram Hamrah; Ula Jurkunas; Debra A Schaumberg; Reza Dana
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

10.  Interferon gamma expression and clinical features in patients with acute retinal necrosis syndrome.

Authors:  Toshiaki Abe; Masami Sato; Yoko Saigo; Makoto Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-20       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.